NEW YORK (GenomeWeb) – Personal Genome Diagnostics announced today that it has partnered with Illumina to develop two in vitro cancer diagnostics.

According to PGDx, the tests will be designed to detect and characterize tumor DNA from tissue or plasma samples, and will run on Illumina's sequencing instruments. Additional terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.